Table 1.
Baseline characteristics
| Parameters | Conventional group (n = 32) | Intensive group (n = 34) |
|---|---|---|
| Age (year) | 67.13 ± 9.44 | 65.76 ± 10.00 |
| Gender (male/female) | 20/12 | 23/11 |
| Mean blood pressure (mm Hg) | 75.34 ± 16.21 | 77.32 ± 14.16 |
| Heart rate (beat/min) | 86.94 ± 25.90 | 82.62 ± 25.71 |
| Hypertension (%) | 13(40) | 15(44) |
| Diabetes (%) | 9(28) | 11(32) |
| Smoking (%) | 8(25) | 10(29) |
| Statins (%) | 9(28) | 11(32) |
| Angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker (%) | 9(28) | 11(32) |
| β‐Blockers (%) | 10(31) | 12(35) |
| Number of stents | 1.72 ± 0.59 | 1.82 ± 0.57 |
| Doses of contrast | 151.41 ± 48.73 | 157.06 ± 46.30 |
| High‐sensitivity troponin T (pg/mL) | 297.19 ± 396.58 | 382.83 ± 406.58 |
| N‐terminal pro‐brain natriuretic peptide (pg/mL) | 954.96 ± 1332.63 | 1086.21 ± 1337.35 |
| Low‐density lipoprotein cholesterol (mmol/L) | 2.71 ± 0.85 | 2.94 ± 0.92 |
| Scr (μmol/L) | 70.63 ± 19.40 | 70.39 ± 19.73 |